- Home
- CVAC vs BZAI Comparison
CVAC vs BZAI Comparison
Compare CVAC & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- BZAI
- Stock Information
- Founded
- CVAC 2000
- BZAI 2010
- Country
- CVAC Germany
- BZAI United States
- Employees
- CVAC N/A
- BZAI N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- BZAI
- Sector
- CVAC Health Care
- BZAI
- Exchange
- CVAC Nasdaq
- BZAI Nasdaq
- Market Cap
- CVAC 818.8M
- BZAI 684.9M
- IPO Year
- CVAC 2020
- BZAI N/A
- Fundamental
- Price
- CVAC $2.77
- BZAI $2.02
- Analyst Decision
- CVAC Hold
- BZAI Strong Buy
- Analyst Count
- CVAC 3
- BZAI 1
- Target Price
- CVAC $10.00
- BZAI $10.00
- AVG Volume (30 Days)
- CVAC 620.8K
- BZAI 904.1K
- Earning Date
- CVAC 05-22-2025
- BZAI 05-15-2025
- Dividend Yield
- CVAC N/A
- BZAI N/A
- EPS Growth
- CVAC N/A
- BZAI N/A
- EPS
- CVAC N/A
- BZAI N/A
- Revenue
- CVAC $70,565,734.00
- BZAI $1,554,000.00
- Revenue This Year
- CVAC $742.57
- BZAI N/A
- Revenue Next Year
- CVAC N/A
- BZAI N/A
- P/E Ratio
- CVAC N/A
- BZAI N/A
- Revenue Growth
- CVAC 75.11
- BZAI N/A
- 52 Week Low
- CVAC $2.22
- BZAI $1.70
- 52 Week High
- CVAC $5.28
- BZAI $29.61
- Technical
- Relative Strength Index (RSI)
- CVAC 38.24
- BZAI N/A
- Support Level
- CVAC $2.78
- BZAI N/A
- Resistance Level
- CVAC $3.33
- BZAI N/A
- Average True Range (ATR)
- CVAC 0.15
- BZAI 0.00
- MACD
- CVAC -0.00
- BZAI 0.00
- Stochastic Oscillator
- CVAC 8.20
- BZAI 0.00
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BZAI Blaize Holdings Inc. Common Stock
Blaize Holdings Inc provides customized,programmable processor architecture suite, artificial intelligence (AI)-enabled edge computing solutions. The company offers semiconductor and software technology company dedicated to revolutionizing the world of AI.